Cargando…

Immuno-genomic landscape of osteosarcoma

Limited clinical activity has been seen in osteosarcoma (OS) patients treated with immune checkpoint inhibitors (ICI). To gain insights into the immunogenic potential of these tumors, we conducted whole genome, RNA, and T-cell receptor sequencing, immunohistochemistry and reverse phase protein array...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chia-Chin, Beird, Hannah C., Andrew Livingston, J., Advani, Shailesh, Mitra, Akash, Cao, Shaolong, Reuben, Alexandre, Ingram, Davis, Wang, Wei-Lien, Ju, Zhenlin, Hong Leung, Cheuk, Lin, Heather, Zheng, Youyun, Roszik, Jason, Wang, Wenyi, Patel, Shreyaskumar, Benjamin, Robert S., Somaiah, Neeta, Conley, Anthony P., Mills, Gordon B., Hwu, Patrick, Gorlick, Richard, Lazar, Alexander, Daw, Najat C., Lewis, Valerae, Futreal, P. Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035358/ https://www.ncbi.nlm.nih.gov/pubmed/32081846 http://dx.doi.org/10.1038/s41467-020-14646-w

Ejemplares similares

MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma
por: Conley, Anthony P., et al.
Publicado: (2019)

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
por: Roszik, Jason, et al.
Publicado: (2017)

Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations
por: Somaiah, Neeta, et al.
Publicado: (2018)

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
por: Carmagnani Pestana, Roberto, et al.
Publicado: (2023)

Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
por: Moyers, Justin T., et al.
Publicado: (2023)

Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report
por: Conley, Anthony P., et al.
Publicado: (2017)

Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin
por: Beird, Hannah C., et al.
Publicado: (2018)

FusionPathway: Prediction of pathways and therapeutic targets associated with gene fusions in cancer
por: Wu, Chia-Chin, et al.
Publicado: (2018)

Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma
por: Beird, Hannah C., et al.
Publicado: (2023)

PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma
por: Parkes, Amanda, et al.
Publicado: (2020)

Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
por: Keung, Emily Z., et al.
Publicado: (2018)

Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion
por: Quintana, Raymundo A., et al.
Publicado: (2017)

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials
por: Groisberg, Roman, et al.
Publicado: (2017)

Artificial intelligence and digital pathology: Opportunities and implications for immuno-oncology
por: Sobhani, Faranak, et al.
Publicado: (2021)

Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma
por: Rathore, Richa, et al.
Publicado: (2021)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors
por: Dembla, Vikas, et al.
Publicado: (2017)

Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets
por: Roszik, Jason, et al.
Publicado: (2019)

Health-Related Quality of Life and Survival Outcomes of Pediatric Patients With Nonmetastatic Osteosarcoma Treated in Countries With Different Resources
por: Bishop, Michael W., et al.
Publicado: (2017)

Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022)

Emerging Data on the Safety and Efficacy of Ripretinib for the Treatment of Gastrointestinal Stromal Tumors
por: Thirasastr, Prapassorn, et al.
Publicado: (2023)

Celebrating a decade of the Journal for ImmunoTherapy of Cancer
por: Romero, Pedro J, et al.
Publicado: (2022)

Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing
por: Truong, Danh D., et al.
Publicado: (2023)

Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022)

New drugs and combinations for the treatment of soft-tissue sarcoma: a review
por: Somaiah, Neeta, et al.
Publicado: (2012)

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma
por: Roszik, Jason, et al.
Publicado: (2021)

Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients
por: Schvartsman, Gustavo, et al.
Publicado: (2017)

Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)
por: Beird, Hannah C., et al.
Publicado: (2019)

Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor
por: Menegaz, Brian A., et al.
Publicado: (2017)

Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association
por: Wu, Chia-Chin, et al.
Publicado: (2022)

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience
por: Tarek, Nidale, et al.
Publicado: (2020)

Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials
por: Livingston, J. Andrew, et al.
Publicado: (2016)

Development of an Enzyme-linked Immuno-Sorbent Assay (ELISA) Method for Carbofuran Residues
por: Yang, Jinyi, et al.
Publicado: (2008)

TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm
por: Beird, Hannah, et al.
Publicado: (2023)

The Wall Street MBA
por: Advani, Reuben
Publicado: (2012)

The Wall Street MBA: Your Personal Crash Course in Corporate Finance
por: Advani, Reuben
Publicado: (2018)

Financial freedom: a guide to achieving lifelong wealth and security
por: Advani, Reuben
Publicado: (2013)

A tool for discovering drug sensitivity and gene expression associations in cancer cells
por: Qin, Yong, et al.
Publicado: (2017)

SARS-CoV-2 vaccines–induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?
por: Reuben, Rine Christopher, et al.
Publicado: (2021)

Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_is0c4l395vjcch8mn5i9natsl5